What is ImmuCell Corporation?
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours and Mastitis. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 99.28M, and a P/E ratio of 57.5x.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 0 |
| 3-6months | 0 | 18,000 shares $76k |
| 6-9months | 0 | 0 |
| 9-12months | 0 | 513,051 shares $64k |